155 related articles for article (PubMed ID: 34646021)
1. Structure of Venezuelan equine encephalitis virus with its receptor LDLRAD3.
Ma B; Huang C; Ma J; Xiang Y; Zhang X
Nature; 2021 Oct; 598(7882):677-681. PubMed ID: 34646021
[TBL] [Abstract][Full Text] [Related]
2. Structure of Venezuelan equine encephalitis virus in complex with the LDLRAD3 receptor.
Basore K; Ma H; Kafai NM; Mackin S; Kim AS; Nelson CA; Diamond MS; Fremont DH
Nature; 2021 Oct; 598(7882):672-676. PubMed ID: 34646020
[TBL] [Abstract][Full Text] [Related]
3. LDLRAD3 is a receptor for Venezuelan equine encephalitis virus.
Ma H; Kim AS; Kafai NM; Earnest JT; Shah AP; Case JB; Basore K; Gilliland TC; Sun C; Nelson CA; Thackray LB; Klimstra WB; Fremont DH; Diamond MS
Nature; 2020 Dec; 588(7837):308-314. PubMed ID: 33208938
[TBL] [Abstract][Full Text] [Related]
4. Entry receptor LDLRAD3 is required for Venezuelan equine encephalitis virus peripheral infection and neurotropism leading to pathogenesis in mice.
Kafai NM; Janova H; Cain MD; Alippe Y; Muraro S; Sariol A; Elam-Noll M; Klein RS; Diamond MS
Cell Rep; 2023 Aug; 42(8):112946. PubMed ID: 37556325
[TBL] [Abstract][Full Text] [Related]
5. 4.4 Å cryo-EM structure of an enveloped alphavirus Venezuelan equine encephalitis virus.
Zhang R; Hryc CF; Cong Y; Liu X; Jakana J; Gorchakov R; Baker ML; Weaver SC; Chiu W
EMBO J; 2011 Aug; 30(18):3854-63. PubMed ID: 21829169
[TBL] [Abstract][Full Text] [Related]
6. Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity.
Kendra JA; de la Fuente C; Brahms A; Woodson C; Bell TM; Chen B; Khan YA; Jacobs JL; Kehn-Hall K; Dinman JD
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852852
[TBL] [Abstract][Full Text] [Related]
7. Mutations in Hypervariable Domain of Venezuelan Equine Encephalitis Virus nsP3 Protein Differentially Affect Viral Replication.
Meshram CD; Phillips AT; Lukash T; Shiliaev N; Frolova EI; Frolov I
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694937
[TBL] [Abstract][Full Text] [Related]
8. Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Erasmus JH; Seymour RL; Kaelber JT; Kim DY; Leal G; Sherman MB; Frolov I; Chiu W; Weaver SC; Nasar F
J Virol; 2018 Feb; 92(4):. PubMed ID: 29187545
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
[TBL] [Abstract][Full Text] [Related]
10. Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses.
Rico AB; Phillips AT; Schountz T; Jarvis DL; Tjalkens RB; Powers AM; Olson KE
Virology; 2016 Dec; 499():30-39. PubMed ID: 27632563
[TBL] [Abstract][Full Text] [Related]
11. Small molecule inhibitors of Ago2 decrease Venezuelan equine encephalitis virus replication.
Madsen C; Hooper I; Lundberg L; Shafagati N; Johnson A; Senina S; de la Fuente C; Hoover LI; Fredricksen BL; Dinman J; Jacobs JL; Kehn-Hall K
Antiviral Res; 2014 Dec; 112():26-37. PubMed ID: 25448087
[TBL] [Abstract][Full Text] [Related]
12. Protein Phosphatase 1α Interacts with Venezuelan Equine Encephalitis Virus Capsid Protein and Regulates Viral Replication through Modulation of Capsid Phosphorylation.
Carey BD; Ammosova T; Pinkham C; Lin X; Zhou W; Liotta LA; Nekhai S; Kehn-Hall K
J Virol; 2018 Aug; 92(15):. PubMed ID: 29769351
[TBL] [Abstract][Full Text] [Related]
13. Locking and blocking the viral landscape of an alphavirus with neutralizing antibodies.
Porta J; Jose J; Roehrig JT; Blair CD; Kuhn RJ; Rossmann MG
J Virol; 2014 Sep; 88(17):9616-23. PubMed ID: 24920796
[TBL] [Abstract][Full Text] [Related]
14. Venezuelan equine encephalitis virus E1 protein interacts with PDIA6 and PDI inhibition reduces alphavirus production.
Panny L; Akrhymuk I; Bracci N; Woodson C; Flor R; Elliott I; Zhou W; Narayanan A; Campbell C; Kehn-Hall K
Antiviral Res; 2023 Apr; 212():105560. PubMed ID: 36822370
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of Venezuelan Equine Encephalitis Virus Identified Based on Host Interaction Partners of Viral Non-Structural Protein 3.
Bakovic A; Bhalla N; Alem F; Campbell C; Zhou W; Narayanan A
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452398
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing antibodies protect mice against Venezuelan equine encephalitis virus aerosol challenge.
Kafai NM; Williamson LE; Binshtein E; Sukupolvi-Petty S; Gardner CL; Liu J; Mackin S; Kim AS; Kose N; Carnahan RH; Jung A; Droit L; Reed DS; Handley SA; Klimstra WB; Crowe JE; Diamond MS
J Exp Med; 2022 Apr; 219(4):. PubMed ID: 35297953
[TBL] [Abstract][Full Text] [Related]
17. Venezuelan Equine Encephalitis Virus Induces Apoptosis through the Unfolded Protein Response Activation of EGR1.
Baer A; Lundberg L; Swales D; Waybright N; Pinkham C; Dinman JD; Jacobs JL; Kehn-Hall K
J Virol; 2016 Jan; 90(7):3558-72. PubMed ID: 26792742
[TBL] [Abstract][Full Text] [Related]
18. The SD1 Subdomain of Venezuelan Equine Encephalitis Virus Capsid Protein Plays a Critical Role in Nucleocapsid and Particle Assembly.
Reynaud JM; Lulla V; Kim DY; Frolova EI; Frolov I
J Virol; 2016 Feb; 90(4):2008-20. PubMed ID: 26656680
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2.
Chung DH; Jonsson CB; Tower NA; Chu YK; Sahin E; Golden JE; Noah JW; Schroeder CE; Sotsky JB; Sosa MI; Cramer DE; McKellip SN; Rasmussen L; White EL; Schmaljohn CS; Julander JG; Smith JM; Filone CM; Connor JH; Sakurai Y; Davey RA
PLoS Pathog; 2014 Jun; 10(6):e1004213. PubMed ID: 24967809
[TBL] [Abstract][Full Text] [Related]
20. Venezuelan equine encephalitis virus variants lacking transcription inhibitory functions demonstrate highly attenuated phenotype.
Atasheva S; Kim DY; Frolova EI; Frolov I
J Virol; 2015 Jan; 89(1):71-82. PubMed ID: 25320296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
